BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33203549)

  • 1. A DROP-IN Gamma Probe for Robot-assisted Radioguided Surgery of Lymph Nodes During Radical Prostatectomy.
    Dell'Oglio P; Meershoek P; Maurer T; Wit EMK; van Leeuwen PJ; van der Poel HG; van Leeuwen FWB; van Oosterom MN
    Eur Urol; 2021 Jan; 79(1):124-132. PubMed ID: 33203549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicentre Clinical Trial Evaluating a Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer.
    Everaerts W; Walz J; Abascal Junquera JM; Goffin K; Grootendorst MR; van 't Klooster K; Juanpere N; Valhondo-Rama R; Vidal-Sicart S; Fumado L
    Eur Urol Focus; 2024 Jan; 10(1):32-40. PubMed ID: 37495459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-
    Vreeburg MTA; Azargoshasb S; van Willigen D; Molenaar T; van Oosterom MN; Buckle T; Slof LJ; Klop M; Karakullukcu B; Donswijk M; van der Poel HG; van Leeuwen FWB; Brouwer OR; Rietbergen DDD
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2282-2291. PubMed ID: 36929210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioguided surgery for lymph node metastases in prostate cancer.
    Knipper S; Falkenbach F; Maurer T
    Curr Opin Urol; 2024 Jul; 34(4):266-272. PubMed ID: 38587022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steerable DROP-IN radioguidance during minimal-invasive non-robotic cervical and endometrial sentinel lymph node surgery.
    van Oosterom MN; Diaz-Feijóo B; Santisteban MI; Sánchez-Izquierdo N; Perissinotti A; Glickman A; Marina T; Torné A; van Leeuwen FWB; Vidal-Sicart S
    Eur J Nucl Med Mol Imaging; 2024 Jan; ():. PubMed ID: 38233608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager.
    Oderda M; Grimaldi S; Rovera G; Delsedime L; D'Agate D; Lavagno F; Marquis A; Marra G; Molinaro L; Deandreis D; Gontero P
    Urology; 2023 Dec; 182():e257-e261. PubMed ID: 37669707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy.
    Nguyen HG; van den Berg NS; Antaris AL; Xue L; Greenberg S; Rosenthal JW; Muchnik A; Klaassen A; Simko JP; Dutta S; Sorger JM; Munster P; Carroll PR
    Eur Urol Oncol; 2024 Feb; 7(1):63-72. PubMed ID: 37516587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative Fluorescent Image Guidance for Nerve-Sparing Prostatectomy: A Review of Historical Context and Current Research.
    Mandel A; Das C; Ting R; Kaufmann B; Tewari A
    J Endourol; 2024 Jan; 38(1):30-39. PubMed ID: 37850492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy.
    Hamdy FC; Lamb AD; Tullis IDC; Verrill C; Rombach I; Rao SR; Colling R; Barber PR; Volpi D; Barbera-Martin L; Lopez JF; Omer A; Hewitt A; Lovell S; Niederer J; Lambert A; Snoeck J; Thomson C; Leslie T; Bryant RJ; Mascioni A; Jia F; Torgov M; Wilson I; Gudas J; Wu AM; Olafsen T; Vojnovic B
    Eur J Nucl Med Mol Imaging; 2024 Jun; ():. PubMed ID: 38853153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous innovation in precision radio-guided surgery.
    Vidal-Sicart S; Goñi E; Cebrecos I; Rioja ME; Perissinotti A; Sampol C; Vidal O; Saavedra-Pérez D; Ferrer A; Martí C; Ferrer Rebolleda J; García Velloso MJ; Orozco-Cortés J; Díaz-Feijóo B; Niñerola-Baizán A; Valdés Olmos RA
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(1):39-54. PubMed ID: 37963516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive overview of radioguided surgery using gamma detection probe technology.
    Povoski SP; Neff RL; Mojzisik CM; O'Malley DM; Hinkle GH; Hall NC; Murrey DA; Knopp MV; Martin EW
    World J Surg Oncol; 2009 Jan; 7():11. PubMed ID: 19173715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic transaxillary parathyroidectomy.
    Mohsin K; Alzahrani H; Bu Ali D; Kang SW; Kandil E
    Gland Surg; 2017 Aug; 6(4):410-411. PubMed ID: 28861383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA-targeted fluorescence guidance for robotic-assisted prostatectomy.
    Falkenbach F; Maurer T
    Nat Rev Urol; 2023 Dec; 20(12):704-705. PubMed ID: 37648788
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer.
    Meijer D; Luiting HB; van Leeuwen PJ; Remmers S; Jansen BHE; Bodar YJL; Witteveen T; Schaake EE; van der Poel HG; Wondergem M; Busstra MB; Nieuwenhuijzen JA; Meijnen P; Brabander T; van Moorselaar RJA; Hendrikse NH; Oprea-Lager DE; Roobol MJ; Vis AN
    J Urol; 2021 Apr; 205(4):1100-1109. PubMed ID: 33207138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings.
    Wibmer AG; Chaim J; Lakhman Y; Lefkowitz RA; Nincevic J; Nikolovski I; Sala E; Gonen M; Carlsson SV; Fine SW; Zelefsky MJ; Scardino P; Hricak H; Vargas HA
    J Urol; 2021 Apr; 205(4):1055-1062. PubMed ID: 33207133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for Systematic Magnetic Resonance Imaging Interpretation and Reporting after Partial Prostate Gland Ablation.
    Hu JC; Basourakos SP; Futterer J
    Eur Urol; 2021 Feb; 79(2):167-169. PubMed ID: 33221091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Chemotherapy and Androgen Signaling-targeted Inhibitors in Patients with Metastatic Prostate Cancer.
    de Wit R; Tombal B; Freedland S
    Eur Urol; 2021 Feb; 79(2):170-172. PubMed ID: 33218827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?
    Stonier T; Tin AL; Sjoberg DD; Jibara G; Vickers AJ; Fine S; Eastham J
    J Urol; 2021 Apr; 205(4):1063-1068. PubMed ID: 33216696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer grading, time to go back to the future.
    Egevad L; Delahunt B; Bostwick DG; Cheng L; Evans AJ; Gianduzzo T; Graefen M; Hugosson J; Kench JG; Leite KRM; Oxley J; Sauter G; Srigley JR; Stattin P; Tsuzuki T; Yaxley J; Samaratunga H
    BJU Int; 2021 Feb; 127(2):165-168. PubMed ID: 33206437
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.
    Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
    Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.